Filing Flows › iRhythm Holdings (IRTC) › Recalls, complaints & regulation
iRhythm Holdings (IRTC): recalls and clinical trials
iRhythm Holdings (IRTC) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I); 1 active clinical trial.
Latest recalls
- 2022-11-16 · FDA device · Zio AT Clinical Reference Manual, Part: ALB0031, and Zio AT Important Information Pamphlet, Part: ALB0034. For Zio Ambulatory ECG monitoring system
iRhythm Holdings' latest quarter
iRhythm Holdings, Q3 2026: revenue $222M (+15% year over year), operating margin -14.7%, net loss $29.9M, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
Questions
Has iRhythm Holdings had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
How many clinical trials does iRhythm Holdings have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.